UPDATE: Peptides favored on 1st day of closely watched FDA compounding adcomm

An FDA advisory committee has recommended that four peptide drugs that were previously restricted because of potential safety concerns be restored to the 503A Bulk Drug Substances list, which would remove the limits on how they are produced by compounders. It marks the first four of seven peptide dr